McErlane David

Group President, BiologicsCatalent, Inc. (CTLT) · full profile →Form 4 · filed Dec 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2024Grant(A)11K$011K
Dec 18, 2024Disposed to issuer(D)11K0
Dec 18, 2024Disposed to issuer(D)36K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 18, 2024Disposed to issuer(D)15K0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-137787) within minutes of acceptance. Every field above traces to the original document. Verify it directly: